HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Melusin protects from cardiac rupture and improves functional remodelling after myocardial infarction.

AbstractAIMS:
Melusin is a muscle-specific chaperone protein whose expression is required for a compensatory hypertrophy response to pressure overload. Here, we evaluated the consequences of melusin overexpression in the setting of myocardial infarction (MI) using a comprehensive multicentre approach.
METHODS AND RESULTS:
Mice overexpressing melusin in the heart (TG) and wild-type controls (WT) were subjected to permanent LAD ligation and both the acute response (Day 3) and subsequent remodelling (2 weeks) were examined. Mortality in wild-type mice was significant between Days 3 and 7, primarily due to cardiac rupture, but melusin's overexpression strongly reduced mortality (43.2% in wild-type vs. 27.3% in melusin-TG, P = 0.005). At Day 3 after MI, a time point preceding the mortality peak, TG hearts had increased heat shock protein 70 expression, increased ERK1/2 signalling, reduced cardiomyocyte hyper-contractility and inflammatory cell infiltrates, and increased matricellular protein expression in the infarcted area. At 2 weeks after MI, melusin overexpression conferred a favourable adaptive remodelling characterized by reduced left ventricle dilatation and better preserved contractility in the presence of a comparable degree of hypertrophy. Adaptive remodelling in melusin TG mice was characterized by reduced apoptosis and fibrosis as well as increased cardiomyocyte contractility.
CONCLUSIONS:
Consistent with its function as a chaperone protein, melusin overexpression exerts a dual protective action following MI reducing an array of maladaptive processes. In the early phase after MI, reduced inflammation and myocyte remodelling protect against cardiac rupture. Chronically, reduced myocyte loss and matrix remodelling, with preserved myocyte contractility, confer adaptive LV remodelling.
AuthorsBernhard Unsöld, Axel Kaul, Mauro Sbroggiò, Carola Schubert, Vera Regitz-Zagrosek, Mara Brancaccio, Federico Damilano, Emilio Hirsch, Marc Van Bilsen, Chantal Munts, Karin Sipido, Virginie Bito, Elke Detre, Nana Maria Wagner, Katrin Schäfer, Tim Seidler, Johannes Vogt, Stefan Neef, Annalen Bleckmann, Lars S Maier, Jean Luc Balligand, Caroline Bouzin, Renée Ventura-Clapier, Anne Garnier, Thomas Eschenhagen, Ali El-Armouche, Ralph Knöll, Guido Tarone, Gerd Hasenfuß
JournalCardiovascular research (Cardiovasc Res) Vol. 101 Issue 1 Pg. 97-107 (Jan 01 2014) ISSN: 1755-3245 [Electronic] England
PMID24130190 (Publication Type: Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't)
Chemical References
  • Cytoskeletal Proteins
  • Extracellular Matrix Proteins
  • Heat-Shock Proteins
  • Itgb1bp2 protein, mouse
  • Muscle Proteins
  • Collagen
Topics
  • Animals
  • Apoptosis
  • Collagen (metabolism)
  • Cytoskeletal Proteins (metabolism)
  • Excitation Contraction Coupling
  • Extracellular Matrix Proteins (metabolism)
  • Female
  • Heart Rupture (etiology, metabolism)
  • Heat-Shock Proteins (metabolism)
  • Humans
  • Inflammation (metabolism)
  • Male
  • Mice
  • Mice, Transgenic
  • Muscle Proteins (metabolism)
  • Myocardial Contraction
  • Myocardial Infarction (complications, metabolism)
  • Myocardium (metabolism)
  • Ventricular Remodeling

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: